TipRanks on MSN6h
iX Biopharma’s iXB 401: A Breakthrough in Drug Delivery
X Biopharma Ltd. (SG:42C) has released an update. iX Biopharma Ltd. announced that its novel semaglutide sublingual wafer, iXB 401, achieved 20 ...
MedPage Today19h
Over 50% of U.S. Adults Qualify for Ozempic, Wegovy
More than half of all adults in the U.S. are eligible for semaglutide (Ozempic, Wegovy, Rybelsus), researchers estimated.
BioPharma Dive23h
Syndax secures FDA OK for new kind of leukemia drug
Revuforj is the first so-called menin inhibitor cleared in the U.S., securing FDA approval for use in adults and certain ...